XT
CURX

XTX Topco’s Curanex Pharmaceuticals CURX Stock Holding History

XTX Topco’s Portfolio CURX Stock Details CURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.2K Buy
51,289
+8,904
+21% +$3.34K ﹤0.01% 3485
2025
Q4 		$14K Buy
+42,385
New +$23.3K ﹤0.01% 3136

Other funds holding CURX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

XTX Topco's CURX Position: Q1 2026 in Review

XTX Topco increased its Curanex Pharmaceuticals (CURX) stake by 21% in Q1 2026, buying an estimated $3.34K and bringing the position to 51,289 shares worth $26.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3485.

XTX Topco first reported a position in CURX in Q4 2025 and has held it in 2 quarters since. 8 funds tracked by Wall St. Rank hold CURX as of Q1 2026.

  • XTX Topco held 51,289 shares of Curanex Pharmaceuticals worth $26.2K as of Q1 2026.
  • XTX Topco bought 8,904 Curanex Pharmaceuticals shares in Q1 2026, an estimated $3.34K.
  • Curanex Pharmaceuticals made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3485 holding.
  • XTX Topco first reported a position in Curanex Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 8 funds tracked by Wall St. Rank held Curanex Pharmaceuticals as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.